Intercept Pharmaceuticals/ US45845P1084 /
| 7/1/2022 9:59:55 PM | Chg. +0.33 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 14.13USD | +2.36% | 29,110 Turnover: 404,699.39 |
-Bid Size: - | -Ask Size: - | 14.17 | 13.47 |
GlobeNewswire
3/2
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 F...
GlobeNewswire
2/23
Intercept to Announce Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
GlobeNewswire
12/20/2021
Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to N...
GlobeNewswire
12/9/2021
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for A...
GlobeNewswire
11/18/2021
GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients...
GlobeNewswire
11/15/2021
Intercept Announces New Long-Term Data Demonstrating Potential of Obeticholic Acid to Improve Transp...
GlobeNewswire
11/12/2021
PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the AASLD - The Live...
GlobeNewswire
11/4/2021
Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
GlobeNewswire
11/4/2021
Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business Overview
GlobeNewswire
11/4/2021
Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results
GlobeNewswire
11/3/2021
Intercept Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
11/2/2021
Intercept Announces Late-Breaking Oral Presentation and Poster Presentations at The Liver Meeting
GlobeNewswire
10/27/2021
Intercept to Announce Third Quarter 2021 Financial Results on November 3, 2021
GlobeNewswire
9/21/2021
Intercept to Present at the 2021 Cantor Virtual Global Healthcare Conference
GlobeNewswire
8/11/2021
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
GlobeNewswire
8/11/2021
Intercept Pharmaceuticals Announces Convertible Notes Exchange, New Issuance and Stock Repurchase
GlobeNewswire
7/29/2021
Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
7/19/2021
Intercept to Announce Second Quarter 2021 Financial Results on July 29, 2021
GlobeNewswire
7/12/2021
Virion Therapeutics, LLC Announces the Appointment of M. Michelle Berrey, M.D., M.P.H. and Williamso...
GlobeNewswire
6/21/2021
Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2021
GlobeNewswire
6/15/2021
Intercept to Present at the Raymond James 2021 Human Health Innovation Conference